Craig W. Lindsley, Ph.D.
Affiliations: | 2006- | Pharmacology | Vanderbilt University, Nashville, TN |
Website:
http://www.mc.vanderbilt.edu/labs/lindsley/lindsleycw.htmlGoogle:
"Craig Lindsley"Mean distance: 7.34 | S | N | B | C | P |
Parents
Sign in to add mentorBruce H. Lipshutz | grad student | 1996 | UC Santa Barbara |
Matthew D. Shair | post-doc | Harvard |
Children
Sign in to add traineeEmily Jeanne Lilla | research assistant | 2017- | Vanderbilt |
Pedro Manuel Garcia-Barrantes | grad student | Vanderbilt | |
Evan P. Lebois | grad student | Vanderbilt (Neurotree) | |
Kellie D. Nance | grad student | Vanderbilt | |
Jeanette L Bertron | grad student | 2016- | Vanderbilt |
Richard Nathan Daniels | grad student | 2010 | Vanderbilt |
J. Phillip Kennedy | grad student | 2010 | Vanderbilt |
Olugbeminiyi Fadeyi | grad student | 2011 | Vanderbilt |
Leslie N. Aldrich | grad student | 2012 | Vanderbilt |
Sydney Lear Stoops | grad student | 2012 | Vanderbilt |
Michael L. Schulte | grad student | 2009-2013 | Vanderbilt |
Robert Raymond Lavieri | grad student | 2014 | Vanderbilt |
Timothy J. Senter | grad student | 2010-2015 | Vanderbilt |
Cody J. Wenthur | grad student | 2011-2015 | Vanderbilt |
Caitlin N Kent | grad student | 2019-2020 | |
Kayla J. Temple | post-doc | 2014- | Vanderbilt |
Aaron T Garrison | post-doc | 2018-2019 | Vanderbilt |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Garrison AT, Orsi DL, Capstick RA, et al. (2022) Development of : A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder. Journal of Medicinal Chemistry |
McClenahan SJ, Kent C, Kharade S, et al. (2022) . Molecular Pharmacology |
Bertron JL, Duvernay MT, Mitchell SG, et al. (2021) Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors. Acs Chemical Neuroscience |
Long MF, Capstick RA, Spearing PK, et al. (2021) Development of structurally distinct tricyclic M positive allosteric modulator (PAM) chemotypes - Part 2. Bioorganic & Medicinal Chemistry Letters. 128416 |
Yamada Y, Gilliland K, Xiang Z, et al. (2021) Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compounds. Bioorganic & Medicinal Chemistry Letters. 128342 |
Kent CN, Fulton MG, Stillwell KJ, et al. (2021) Discovery and optimization of a novel CNS penetrant series of mGlu PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model. Bioorganic & Medicinal Chemistry Letters. 127838 |
Reed CW, Kalbfleisch JJ, Wong MJ, et al. (2020) Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu Positive Allosteric Modulator Tool Compound. Acs Medicinal Chemistry Letters. 11: 1773-1779 |
Kalbfleisch JJ, Reed CW, Park C, et al. (2020) Synthesis and SAR of a series of mGlu NAMs based on an ethyl-8-methoxy-4-(4-phenylpiperazin-1-yl)quinoline carboxylate core. Bioorganic & Medicinal Chemistry Letters. 127529 |
Kent CN, Park C, Lindsley CW. (2020) Classics in Chemical Neuroscience: Baclofen. Acs Chemical Neuroscience |
Fulton MG, Loch MT, Rodriguez AL, et al. (2020) Synthesis and pharmacological evaluation of bivalent tethered ligands to target the mGlu heterodimeric receptor results in a compound with mGlu homodimer selectivity. Bioorganic & Medicinal Chemistry Letters. 127212 |